1. Copyright © 2011 American Medical Association. All rights reserved.
From: Lifestyle Modification and Prevention of Type 2 Diabetes in Overweight Japanese With Impaired Fasting Glucose LevelsA Randomized Controlled Trial
Arch Intern Med. 2011;171(15): doi: /archinternmed
Figure Legend:
Figure 1. Flowchart of the study participants, May 1, 2004, through August 31, 2009, in the Zensharen Study for Prevention of Lifestyle Diseases.
Date of download: 10/25/2017
Copyright © 2011 American Medical Association. All rights reserved.

2. Copyright © 2011 American Medical Association. All rights reserved.
From: Lifestyle Modification and Prevention of Type 2 Diabetes in Overweight Japanese With Impaired Fasting Glucose LevelsA Randomized Controlled Trial
Arch Intern Med. 2011;171(15): doi: /archinternmed
Figure Legend:
Figure 2. Estimated cumulative incidence of diabetes by baseline glucose tolerance and assigned groups, May 1, 2004, through August 31, 2009, in the Zensharen Study for Prevention of Lifestyle Diseases. A, Overall findings for the control and frequent intervention (FINT) groups. B, The group with impaired fasting glucose levels and impaired glucose tolerance (IFG + IGT) was defined by the baseline 75-g oral glucose tolerance test as follows: fasting plasma glucose level of less than 126 mg/dL and 2-hour plasma glucose level of at least 140 mg/dL and less than 200 mg/dL (IFG + IGT). C, The group with isolated IFG was defined by the baseline 75-g oral glucose tolerance test as follows: fasting plasma glucose level of less than 126 mg/dL and 2-hour plasma glucose level of less than 140 mg/dL.
Date of download: 10/25/2017
Copyright © 2011 American Medical Association. All rights reserved.